Author： Hüll Michael Berger Mathias
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.66, Iss.16, 2006-01, pp. : 2075-2093
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer's Disease?
By Giacobini E.
CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. :
Access to resources
Recommend
Progress in Colorectal Cancer Chemotherapy: How Far Have We Come, How Far to Go?
By Royce M.E.
Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. :
Vaccines for Alzheimer's Disease: How Close Are We?
By Janus C.
CNS Drugs, Vol. 17, Iss. 7, 2003-01 ,pp. :
The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?
By Johnson N.
PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. :